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A B S T R A C T
Background: While systematic review (SR) methods are gaining traction as a method for providing a reliable
summary of existing evidence for health risks posed by exposure to chemical substances, it is becoming clear that
their value is restricted to a specific range of risk management scenarios - in particular, those which can be
addressed with tightly focused questions and can accommodate the time and resource requirements of a sys-
tematic evidence synthesis.
Methods: The concept of a systematic evidence map (SEM) is defined and contrasted to the function and lim-
itations of systematic review (SR) in the context of risk management decision-making. The potential for SEMs to
facilitate evidence-based decision-making are explored using a hypothetical example in risk management
priority-setting. The potential role of SEMs in reference to broader risk management workflows is characterised.
Results: SEMs are databases of systematically gathered research which characterise broad features of the evi-
dence base. Although not intended to substitute for the evidence synthesis element of systematic reviews, SEMs
provide a comprehensive, queryable summary of a large body of policy relevant research. They provide an
evidence-based approach to characterising the extent of available evidence and support forward looking pre-
dictions or trendspotting in the chemical risk sciences. In particular, SEMs facilitate the identification of related
bodies of decision critical chemical risk information which could be further analysed using SR methods, and
highlight gaps in the evidence which could be addressed with additional primary studies to reduce uncertainties
in decision-making.
Conclusions: SEMs have strong and growing potential as a high value tool in resource efficient use of existing
research in chemical risk management. They can be used as a critical precursor to efficient deployment of high
quality SR methods for characterising chemical health risks. Furthermore, SEMs have potential, at a large scale,
to support the sort of evidence summarisation and surveillance methods which would greatly increase the re-
source efficiency, transparency and effectiveness of regulatory initiatives such as EU REACH and US TSCA.
1. Introduction
Systematic review is the epitome of the evidence-based approaches
that have revolutionized clinical decision-making. The methodology was
developed in response to medical practitioners' need to distill clear and
reliable conclusions about the efficacy of clinical interventions from an
evidence base seemingly full of contradiction, heterogeneity and bias
(Chalmers et al., 2002; Garg et al., 2008; Higgins and Green, 2011). This
need parallels that of chemicals policy; where conclusions regarding the
safety of exposure to a chemical substance must be synthesised from a
significantly more disparate evidence base (Whaley et al., 2016).
Consequently, interest in the application of systematic review to reg-
ulatory decision-making contexts within chemicals policy and wider
environmental health is growing. This is evidenced by the increasing
number of systematic reviews published in the field (Whaley and Halsall,
2016), the establishment of collaborations and workgroups dedicated to
development and dissemination of environmental health systematic re-
view methodology (Morgan et al., 2016; NTP, 2015; Woodruff and
Sutton, 2014), and the adoption and use of systematic review by reg-
ulatory bodies such as the United States Environmental Protection
Agency (US EPA) (EPA, 2018; The National Academies of Sciences,
2017) and World Health Organization (Mandrioli et al., 2018).
https://doi.org/10.1016/j.envint.2019.05.065
Received 28 March 2019; Received in revised form 10 May 2019; Accepted 24 May 2019
⁎ Corresponding author at: Lancaster Environment Centre, Lancaster University, Lancaster, UK.
E-mail address: t.wolffe@lancaster.ac.uk (T.A.M. Wolffe).
Environment International 130 (2019) 104871
0160-4120/ © 2019 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license 
(http://creativecommons.org/licenses/BY/4.0/).
T
Growing interest in systematic review approaches is indicative of
the evolutionary journey chemicals regulation follows as it attempts to
reconcile past oversights with present day knowledge and mounting
future challenges. A number of legacy chemicals released to market
under past regulatory workflows persist on the market without risk
assessment. Meanwhile, an overwhelming number of new chemicals are
presented for assessment each year while awaiting release to market
under modern regulatory workflows (European Comission, 2007; Pool
and Rusch, 2014). This amounts to increasing strain on regulatory
processes, which must operate without a proportionate increase in re-
source availability. While providing and/or gathering relevant data for
new chemicals now forms a vital part of risk assessment, advances in
analytical techniques and scientific understanding continue to broaden
the scope of this data beyond the realms of traditional in vivo toxicity
testing. Although vital for compiling a more complete understanding of
a chemical's toxicity, the broad scope and increasing availability of such
data presents challenges for decision-makers tasked with handling,
appraising and interpreting this data for risk assessment. Failure to have
a transparent structure for considering all relevant data appropriate to
risk assessment (e.g. a stepwise approach for addressing in vitro data
following evidence from in vivo studies or comprehensive assessment of
all in vitro data) reduces stakeholder confidence and has the potential to
bias regulatory decisions. Studies reporting results amenable to the
observer bias of independent assessors, or to the vested interests of non-
independent assessors, may be cherry picked from the wider evidence
base. Even where all relevant studies are considered, the role that sci-
entific judgement plays in the process of appraisal and interpretation of
data can lead to conflicting conclusions between different regulatory
bodies (Whaley et al., 2016). Transparency in identifying both the
evidence and scientific judgement are critical to establishing trust in
decision-making.
Systematic review offers a framework for piecing together this
varied data in a transparent and resource efficient manner, such that a
more complete picture of toxicity can inform regulatory decision-
making. It details methodology for ensuring all such data is identified,
gathered and considered – preventing cherry picking of studies that
only provide part of the complete toxicity profile for a chemical, or that
present biased or unrepresentative results. As well as reducing bias, all
steps of the methodology are designed to maximise transparency. A
well conducted and reported systematic review effectively outlines the
research question, the approach taken to address the question, the
evidence considered, and the scientific judgement applied to reaching
conclusions. Thus, differences across reviews or regulatory bodies can
be effectively identified and explained. Considering the results of all
relevant studies makes maximum use of existing data and increases the
precision of a systematic review's conclusions. This allows reliable de-
cisions to be made without the commissioning of redundant and re-
petitive primary research, or conversely identifies specific knowledge
gaps at which smart testing strategies can be focused.
Although the aim of systematic review (i.e. to transparently and
robustly synthesise all available data in answer to a research question)
aligns well with the needs of chemicals policy, conflicts between the
practicalities associated with the methodology and those associated
with regulatory frameworks hinder their wider uptake, and/or the
production of reviews that are of sufficient quality to produce trust-
worthy results (Kelly et al., 2016; Marshall et al., 2018; Reynen et al.,
2018). Key areas of conflict include the time and resource intensity of
the systematic review process, the scope of the research questions ad-
dressed by the methodology, and the ease with which the output of a
systematic review can be accessed, interpreted and updated. Further,
the fluid and rapidly expanding nature of scientific research and the
chemicals industry creates a constant and pressing need for evidence
surveillance, such that regulators can keep apace of the growing body of
scientific literature and update regulation accordingly. This challenge
demands a responsive and living solution beyond the reach of current
systematic review practice.
In this manuscript, we briefly outline systematic review metho-
dology to illustrate its strengths and highlight the transferable barriers
which have been suggested as preventing its wider uptake in other
fields (Oliver and Dickson, 2016). We discuss how these difficulties may
be addressed through the novel implementation of systematic evidence
mapping in environmental health. Systematic evidence maps (SEMs)
provide a broad and comprehensive overview of an evidence base
(Haddaway, Bernes, Jonsson, & Hedlund, 2016; James et al., 2016).
They facilitate the identification of trends which can be used to inform
more efficient systematic review, or more targeted primary research.
The methodology behind SEMs, and how this might be adapted to suit
the demands and limitations of regulatory decision-making in chemi-
cals policy is discussed, along with the advantages and future potential
of SEMs as a fundamental tool for evidence-informed risk management
and decision-making.
2. The application of systematic review methods in chemical risk
management
The utility and advantages of systematic review methods for ad-
vancing chemical risk assessment have been extensively documented
elsewhere (Aiassa et al., 2015; Hoffmann et al., 2017; Hooijmans et al.,
2012; Rooney et al., 2014; Vandenberg et al., 2016; Whaley et al., 2016;
Woodruff and Sutton, 2014). Systematic review provides a transparent
and reproducible approach to summarising and critically assessing ex-
isting evidence on potential health risks associated with exposure to a
chemical substance. These transparent methods serve to document the
basis of scientific judgments, minimising the potential for bias and error
presented by more traditional narrative approaches in which opinion is
not clearly distinguished from evidence.
The key features of a systematic review (Table 1) are:
• a clearly specified research objective - usually captured in a
Population-Exposure-Comparator-Outcome (PECO) statement• a comprehensive search strategy• screening of the search results - for evidence relevant to addressing
the research objective• extraction of data from included studies - using a prespecified data
extraction framework• critical appraisal of included studies - according to a prespecified set
of quality criteria, usually targeting risk of bias• synthesis of findings from the included studies - using suitable
quantitative statistical methods and otherwise qualitative methods
as appropriate• characterisation of confidence in the evidence for the results of the
synthesis - according to a prespecified set of criteria• statement of conclusions - including an assessment of limitations in
design and conduct of the review itself.
Specific methodological decisions concerning each of these key
features, from definition of the PECO statement to the chosen synthesis
approach, are specified in a pre-published protocol.
However, with the methodology's pursuit of rigor and comprehen-
siveness comes a significant demand for time and resources. Evidence
from medical systematic reviews indicates it takes on average ap-
proximately 70weeks to progress a systematic review from protocol
registration in the PROSPERO registry (National Institute for Health
Research, 2018) to publication of the final systematic review (Borah
et al., 2017). Variance around this average is wide (from 6 to
186weeks), but the significance of person-hours and planning time
prior to protocol registration is not considered in these estimates. More
recent analysis of environmental science systematic reviews estimates
an average of 164 (full time equivalent) person-days required for
completion of systematic reviews (Haddaway and Westgate, 2018).
However, in the absence of comparable evidence in the field of che-
mical risk assessment, these figures agree with anecdotal reports of the
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average systematic review taking around 12 to 18months to progress
from inception to publication. A significant factor which contributes to
the length of the systematic review process is the manual way in which
each step of the methodology is conducted. All studies returned by a
systematic search strategy are generally screened by human reviewers,
in duplicate, one-by-one, before included studies undergo a similarly
manual data extraction and critical appraisal step.
Systematic review management software has been developed (e.g.
“HAWC: Health Assessment Workplace Collaborative,”, 2013;
Covidence, 2019; Evidence Partners, 2019; Science for Nature and
People Partnership Evidence-Based Conservation working group,
Conservation International, Datakind, 2018; Sciome, 2018; Thomas
et al., 2010; CAMARADES-NC3Rs, 2019) to assist human reviewers
with maintaining transparency in SRs and with organising the review
process. Acknowledging the impedance caused by a review's manual
workload, review management software is beginning to incorporate
machine learning as a means of automating labour-intensive tasks (e.g.
Evidence Partners, 2019; Science for Nature and People Partnership
Evidence-Based Conservation working group, Conservation
International, Datakind, 2018; Sciome, 2018; CAMARADES-NC3Rs,
2019). Automation has the potential to result in significantly reduced
workloads and subsequent demands for time and resources (Mara-eves
et al., 2015). Pending further advances, the time and resource demands
of systematic review are at conflict with the intense time/resource
pressure under which regulatory processes must operate (Innvaer et al.,
2002; Oliver and Dickson, 2016).
Also at conflict with the demands of regulatory decision-making is
the narrow scope of systematic reviews, which are designed to address a
specific and clearly defined objective or research question. To ensure a
manageable, relevant and focused review, suitable research questions
are typically closed framed, such that the review can synthesise a
single, coherent answer. These closed-framed questions are well suited
to the decision-making contexts of medicine (the field from which
systematic reviews originate), but may be difficult to apply to chemical
risk assessment. The web of interlinked endpoints, potential variation in
sensitive populations, uncharacterised low dose effects, and unknown
behaviour of a chemical in the environment or in contact with other
chemicals can mean that the decision-critical information which can be
supplied by a tightly focused research question is often not readily
apparent in chemical risk assessment contexts. Even where such a
question can be devised, and the answer reached through systematic
review, the specificity of the research problem and its resolution are
likely to comprise only part of the much broader range of unaddressed
decisions and information requirements faced by risk managers.
3. Systematic evidence maps for chemical risk management
In light of the time and resource intensity of current systematic
review practice, identifying the most informative research questions is
important for maximising the value and efficiency of systematic reviews
in regulatory decision-making. Investing resources in systematic review
as a means of addressing specific research questions is inefficient if
there is a lack of data available for answering those questions. Devising
specific research questions therefore becomes a reactive process, rather
than a proactive one. This is at odds with the goals of chemicals policy,
which aims to predict and prevent harm as a result of exposure to
chemical substances.
Decision-makers therefore need to monitor and understand the
evidence base as a whole – such that emerging trends or issues of po-
tential concern can be identified and investigated in a timely manner.
Identifying trends in the evidence base, including evidence clusters and
evidence gaps, facilitates the formulation of proactive research ques-
tions by relevant stakeholders. Reviewers need not rely on environ-
mental health outcomes becoming infamous or epidemic as an indicator
of sufficient evidence for an efficient and valuable synthesis. Instead,
trends in the availability of evidence ensure prevention of synthesis
attempts for which there is insufficient data (or for which syntheses
already exist) and promote the targeting of primary research efforts at
evidence gaps. This kind of evidence surveillance has traditionally been
the domain of scoping reviews. These reviews are often narrowly fo-
cused precursors to systematic reviews. Thus a specific systematic re-
view question has already begun to be framed, and the literature scoped
for sufficient data to address/focus it – rather than vice versa (e.g.
Bolden et al., 2017). Scoping reviews also typically present their find-
ings in tabular format. This compromises the accessibility of the evi-
dence they scope, and makes them ill-suited for applications beyond
determining whether there is sufficient literature to merit a systematic
review (Grant and Booth, 2009).
Instead, the introduction of systematic evidence mapping, a meth-
odology recently adapted from the social sciences (Clapton et al., 2009)
for environmental management (James et al., 2016), has the potential
to facilitate evidence surveillance in a transparent and reproducible
manner, providing a broader understanding of the extant evidence base
through interactive outputs.
Table 1
The key features of systematic reviews and their primary advantages. PECO=Population-Exposure-Comparator-Outcome.
Systematic review step Primary advantages
Pre-published protocol Reduces risk that expectation bias will influence reviewers' choice of methods and approaches for analysis mid-review; if
formally published, external peer review can reduce risk of limitations in planned methods from compromising final results.
Statement of objectives Provides a structured framework for the aims of the review (including specific statement of the research question and PECO
criteria) against which appropriate review methods can be defined.
Comprehensive search Reduces risk of only partial retrieval of the overall body of evidence that is relevant to answering the research question.
Screening against eligibility criteria (study
inclusion)
Reduces risk of only partial retrieval of the overall body of evidence that is relevant to answering the research question, in
particular the risk of selection bias when reviewers are deciding which evidence to include in the review.
Data extraction using appropriate extraction tools Reduces risk of inconsistent or partial retrieval of data from studies included in the review, reducing risk of selective use of
data from studies deemed relevant to answering the research question.
Critical appraisal of included studies Encourages consistent assessment of validity of included studies according to factors internal to study design, reducing risk of
expectation bias or other factors causing studies to be inappropriately weighted, and helping ensure that bias in the findings
of the included studies is not transmitted through to the findings of the review.
Synthesis of included studies Pooling or integration of sufficiently comparable studies increases the power of an analysis, whether quantitative or
qualitative, allowing overall trends in results to be more reliably identified.
Characterisation of confidence in the evidence Encourages consistent assessment of the validity of the results of the synthesis according to features which manifest at the
level of body of evidence as a whole rather than the individual study. Outlining the scientific judgement applied in rating
confidence is key to the transparency of subsequent conclusions.
Drawing conclusions/key review output Qualitative and/or quantitative summary effect estimates help direct policy decisions based on permissible exposure levels
and related controls; assessment of limitations in the review methods helps ensure that any residual potential biases in the
review are made clear to the reader and can additionally be accounted for in uncertainty assessment and consequent risk
management action.
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Table 2
A comparison of systematic review and systematic evidence mapping methodology and their respective roles in risk management decision-making (adapted from
James et al., 2016). SR= systematic review, SEM= systematic evidence map, RM= risk management, TDI= tolerable daily intake.
Step Conduct of step in SRs related to assessing
chemical health risks
Conduct of step in SEMs related to assessing
chemical health risks
SR vs SEM for responding to risk management
needs
Pre-published protocol Define all methods in advance of conduct of
review
Same Provides transparency; reduces bias; opportunity
for peer review and stakeholder engagement.
Applies to both SRs and SEMs.
Statement of objectives Question concerns the effect of an exposure on
health; or the effect of intervening to reduce
exposure in terms of health benefit. Usually
targets a single or few exposures and outcomes.
Question concerns the state of the evidence
base for a topic. Usually open-ended and
encompassing a range of multiple related
exposures and outcomes.
SR: Focused, closed questions of SRs best service
specific RM decisions such as characterising
specific health risks/TDIs.
SEM: Open questions of SEMs best service
scenarios in which evidence should be surveyed
and scoped, such as problem identification and
priority-setting.
Comprehensive search Search terms highly resolved and specified for
most key elements of the objective statement,
returning a moderate volume of evidence.
Wide ranging search strings of lower
specificity based on topic rather than defining
all key elements of the objective in the search.
SR: Narrow searches efficiently identify evidence
related to exposure-outcome pairs. Maximum
feasible number of sources searched to ensure
collation of all relevant evidence for synthesis.
SEM: Broader, topic-based SEM search allows
evidence supportive of multiple decision scenarios
to be identified. Flexible number of sources
searched, or sources searched in a step-wise





Inclusion criteria specified in detail for all key
elements of the objective.
Inclusion criteria defined in terms of topic
rather than key elements of the objective.
SR: As for search, specific inclusion criteria ensure
SRs efficiently service a specific research question.
SEM: Broad objectives ensure inclusion of




Complete extraction of meta-data and study
findings.
Extraction of meta-data; optional extraction
of study findings and other study
characteristics depending on SEM objectives.
SR: Data extraction determined by objectives.
SEM: Data extraction more flexible and can
respond to needs of risk management process to
develop fit-for-purpose maps of varying degrees of
comprehensiveness.
Coding of extracted data
using controlled
vocabularies
Coding facilitates grouping of included studies
for synthesis/integration according to review
objectives. Coding is closely related to review
objectives and data extraction process,
whereby narrow research question and PECO
statement inherently define specific code
applicable to raw extracted data.
Coding facilitates broad comparison of
heterogeneous data across an evidence base.
Broad map objectives necessitate extensive
coding process, whereby specific code must
be defined in a step distinct from the
formulation of end-users' specific research
questions.
SR: Tight review objectives pre-specify applied
code (e.g. considering ages 0–18 as ‘Child’ for
reviews focusing on a population of ‘Children’).
Narrower range, or greater specificity of
controlled vocabulary terms applicable per item of
extracted data.
SEM: Code pre-specified where possible, but
addition of new terms (which could not be
accounted for a priori) considered flexible. Any
one item of extracted data may be coded by
multiple and variably resolved terms. Openly
accessible ontologies may be used for coding to
promote consistency and interoperability.
Critical appraisal of
included studies
Assessment of internal validity (risk of bias)
conducted for all included studies.
Study validity assessment is optional and to
some extent restricted if outcome is not a
defined aspect of the SEM; study
characteristics relevant to risk of bias
assessment can be extracted.
SR: Describe the internal validity of the evidence
base, which is an essential step of characterising
confidence in the evidence.
SEM: Flexible, critical appraisal step can be
omitted; study methods are mapped or
methodological quality assessed to goals, can be
part of stepwise approach where quality only
assessed for studies addressing key outcomes etc.
Synthesis of included
studies
Quantitative synthesis where possible to
produce characterisation of hazard from
exposure; qualitative synthesis where pooling
studies is not possible.
Reports of systematic maps can provide
narrative synthesis of characteristics of the
evidence key to a given decision-making
context.
SR: Synthesis supports a specific type of decision
context.
SEM: Primary output is a more context-agnostic
database which can be used by risk managers to
support multiple decisions in the RM workflow; or




Assessment of confidence or certainty in the
results of the synthesis, according to
characteristics of the evidence base taken as a
whole.
SEMs do not synthesise included studies.
SEMs help identify regions of evidence with
characteristics indicative of being worth
further, detailed analysis in support of a
prospective decision.
SR: Provide detailed conclusions on certainty of
evidence in hazard characterisation or to support
risk assessments.
SEM: Support a range of decisions, particularly
decisions to focus research and review, e.g.
indicating clusters where evidence may be strong
enough to warrant SR (e.g. have a reasonable
likelihood of changing a TDI), fill in gaps to reduce
uncertainty and for surveillance.
Drawing conclusions/key
review outputs
SRs primarily provide a summary effect
estimate and surrounding uncertainty based on
strength of the evidence and review methods.
SEMs primarily provide a searchable database
of the characteristics of the evidence base,
making the knowledge base locked away in
manuscripts accessible to decision-makers.
SR: provide a qualitative and/or quantitative
summary effect estimate in answer to a narrow
and specific decision-making question.
SEM: identify evidence gluts for synthesis. When
combined with an understanding of RM needs,
transparent criteria for prioritization of gluts for
synthesis and gaps for commissioning primary
research can be presented.
T.A.M. Wolffe, et al. Environment International 130 (2019) 104871
4
The methodological steps involved in constructing a systematic
evidence map are similar to those involved in the initial stages of
producing a systematic review (see Table 2, adapted from James et al.,
2016) whereby a systematic search strategy is employed to collate
evidence, which is subsequently screened for relevance before under-
going data extraction. The key difference between the methodologies
comes in the form of their aims and subsequent outputs. Systematic
reviews collate a relatively narrow subset of the evidence base to an-
swer a specific research question. Conversely, SEMs do not attempt to
answer a specific, closed-framed research question, and are instead
guided by much broader research objectives. SEMs collate a sufficiently
broad subset of evidence such that many different specific research
questions might be formulated from, and addressed with, a single sys-
tematic evidence map. SEMs are concerned with characterising the
evidence base within a given research area, such that the availability,
type and features of the evidence can be clearly mapped and explored
through data visualization.
To facilitate this exploration, the output of a SEM takes the form of a
queryable database (Clapton et al., 2009; James et al., 2016) as opposed
to the lengthy and technical documents which form the main output of
a systematic review. The database format allows users to query the
evidence base according to their research interests, providing func-
tionality which is void from systematic review documents and their
associated static data tables. This format addresses the inability of
systematic evidence mappers to predict what the specific research in-
terests of users might be by providing the option to search for, and
select, the specific subsets of data relevant to a particular use case.
Whereas systematic reviews present users with select information
from included studies (i.e. data relevant to addressing the research
question), SEMs aim to extract a broader range of data from included
studies and aim to maintain the native format of these data. In this
sense, the search and screening process are the steps of SEM metho-
dology most affected by its research objective or context, as the focus of
data extraction remains broad regardless. This is in contrast to sys-
tematic review, where all steps are heavily influenced by its research
question. The data extracted for inclusion in a SEM database can then
be flexibly categorised, or “coded” to facilitate comparison of an
otherwise heterogeneous evidence base.
Resolution of coding can be adapted to suit the needs of regulators.
For example, coding the species under investigation in a study might
use categories such as “Sprague-Dawley”, “Rat”, “Rodent” or
“Mammal”; or may use all of these categories such that the data can be
interrogated in successively deeper levels of detail. As well as facil-
itating variably resolved interrogation of the evidence base, coding
plays a significant role in systematic mapping's amenability to up-
dating. Use of universal, standardised ontologies for coding, such as the
Unified Medical Language System (UMLS) (U.S. National Library of
Medicine, 2016), offers a degree of consistency that future users can
readily exploit when updating a map (Baker et al., 2018). These
ontologies also offer interoperability between SEMs, creating the po-
tential to expand and merge evidence maps – a feature likely to become
increasingly attractive as the scope of evidence relevant to assessing
toxicity grows along with our understanding of its interconnectedness.
In current practice it is common to present users with SEMs that
house only coded information for simplicity and ease of access (e.g.
Papathanasopoulou et al., 2016). However, this conflates data extrac-
tion with coding. Maintaining the native format of extracted data and
applying coding on top of this therefore ensures maximum transparency
in SEMs. This additionally promotes the ease with which a map can be
updated as advancing scientific understanding calls for coding cate-
gories to be redefined. As with systematic reviews, the data extraction
and coding steps of a SEM represent a manual workload. Presenting
only coded data may offer a saving in the resource intensity of the
process. However, in maintaining a transparent link between raw ex-
tracted data and the code used to categorise it, SEMs offer a gateway to
automation – whereby controlled vocabulary ontologies can be used to
train machine learning algorithms to automatically identify, extract and
code data from the literature.
Pending such advances, the time required to conduct a fit for pur-
pose systematic map in environmental health is uncharacterised.
Evidence from the wider environmental sciences (Haddaway and
Westgate, 2018) suggests that (on average) systematic maps take longer
to complete than systematic reviews. This is due to the generally larger
number of studies they manually collate, screen and extract data from.
While maps might present a larger upfront cost in terms of time, their
multipurpose nature has the potential to offer more long-term resource
savings compared to exclusively conducting systematic reviews. This is
because a single systematic evidence map may continue to be useful to
several different aspects of the regulatory workflow (see Sections 4 and
5 below).
As the purpose of a SEM is to characterise the evidence base, there is
no risk of allocating resources to the production of an inconclusive
output, as is the case for “empty” systematic reviews (systematic re-
views which ask research questions for which there is too little included
evidence for them to reach a conclusion or be supportive of a decision).
In fact, systematic evidence maps may reduce the resource strain as-
sociated with systematic reviews. A SEM's broad overview of the evi-
dence base allows fast identification of topics for which there is suffi-
cient data to warrant a full systematic review. The SEM itself, if
conducted to sufficiently rigorous standards, can even replace the lit-
erature search and screening process of a systematic review. As SEMs
present all available relevant evidence on a broader topic such as the
“health effects of bisphenol-A" (obtained through a systematic but less
specific search strategy), filtering this information according to the
PECO statement of a systematic review may act in an equivalent
manner to approaching the literature with a more focused search
strategy in the first instance. The pre-screened nature of this subset is
likely to reduce the number of false positive results, facilitating faster
syntheses.
As advances in machine learning facilitate more highly resolved
data extraction processes, future SEMs may even store enough detail for
them to form the basis of meta-analytical syntheses. If all data con-
tained within study reports is extracted and indexed within a SEM,
there would be no data required specifically for syntheses which could
not be found in the SEM. This would allow SEMs to form the dataset on
which meta-analytical and predictive toxicological models are based,
the results of which may additionally be incorporated into the SEM
itself – facilitating more transparent, resource-efficient and easily up-
dated syntheses.
4. Exploring the evidence base with SEMs
Systematic evidence mapping facilitates identification of trends
which are informative for many risk management scenarios. To illus-
trate the flexibility and potential utility of SEMs' trendspotting capacity,
this section highlights the type of data visualization and exploration
possible through querying subsets of information in a SEM database.
Specifically, “priority setting” (National Academy of Sciences, 1983;
Pool and Rusch, 2014), the process by which regulators identify the
most pressing chemical substances for assessment and regulation (e.g.
from a pool of unassessed legacy chemicals) is presented as context for
the exploration of a hypothetical SEM.
Several factors are relevant to prioritizing individual chemicals for
assessment, broadly ranging from recorded levels of exposure to evi-
dence for toxicity. Underlying these broad considerations are several
more specific factors such as the bio-accessibility of the chemical, the
relevance of its toxicity evidence for predicting health risks in human
populations etc. In order to make the most efficient use of resources and
the systematic review process, decision-makers require access to a
means of comparing these features to justify prioritization of a parti-
cular chemical for review/risk assessment.
This is the role of a SEM, which may be constructed with the aim of
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Fig. 1. The process of identifying trends and exploring the evidence landscape involves querying the SEM database and visualizing the results of the query. Queries
may start by asking broader questions which consider a wider range and volume of data (e.g. Queries 1 and 2). Users may then further explore any trends of interest
discovered in the results of these broad queries by running narrower queries which consider a more specific subset of data (e.g. Queries 3 and 4). Data displayed in
this Figure have been artificially generated to illustrate a hypothetical use case for SEMs. FR = flame retardant, TDI = tolerable daily intake, SEM = systematic
evidence map.
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identifying and characterising the risk assessment relevant evidence for
a broader group of legacy chemicals, e.g. flame retardants. Once data
has been extracted and coded from the literature, the SEM can be ex-
plored with a succession of queries of increasingly narrow focus, each
considering a narrower subset of the evidence base than the last, such
that a research question appropriate for more detailed synthesis is re-
solved at the end of a process which begins with a very broad research
objective. This is illustrated in Fig. 1 using the hypothetical context of
priority setting with a group of arbitrary chemicals, in this case flame
retardants (FRs) A–F.
Queries 1 and 2 depicted in Fig. 1 explore the frequency with which
the literature observes a flame retardant in a coded location category
(e.g. human blood, human breast milk, house dust, etc.) and the fre-
quency with which the literature observes an association between a
flame retardant and a coded toxicity category (e.g. reproductive toxi-
city, neurotoxicity etc.). The heatmap visualizing the results of Query 1
shows a comparatively large number of observations of FRs A and B in
location categories directly relevant to human populations (i.e. human
blood and breast milk). Query 2 clarifies whether these observations
require further attention by indicating what kind of toxicity informa-
tion is available for each flame retardant. The bar chart visualization
indicates comparable numbers of observations for most of the flame
retardants and types of toxicity but a comparatively large number of
observations that associate FR B with neurotoxicity.
Based on (hypothetical) existing evidence, Queries 1 and 2 indicate
flame retardants A and B as potential candidates for full assessment.
Resolving which to prioritize involves accessing more study-specific
information through a series of queries which consider a successively
narrow subset of the evidence base. Despite availability of toxicity data,
observing flame retardants in human relevant locations might not be
concerning if the concentrations observed are negligible. Thus Query 3
examines the range of concentrations reported in the literature for FRs
A and B in human blood and breast milk. Visualization of Query 3 in-
dicates a wider range of lower concentrations reported for FR A, com-
pared to a narrower range of higher concentrations for FR B. Query 4
then examines the relevance of these concentrations against the current
estimated tolerable daily intake (TDI) for FR B, indicating several ob-
servations of toxicity below the current TDI and supporting prioritiza-
tion of FR B for assessment. Further, the relatively large volume of
observations of neurotoxicity may indicate sufficient data available to
conduct a systematic review on FR B's relationship with neurotoxicity.
However, it is important to distinguish the results of SEM queries
from synthesis. SEMs only present what has been studied in the lit-
erature – they cannot present what has not been studied, and do not
always assess the risk of bias of the findings they report. Thus, while a
high number of observations of flame retardants A and B in human
relevant locations is a valid trend to explore further, it does not ne-
cessarily mean that there are fewer of the other flame retardants pre-
sent in human relevant locations, but rather that there may simply be
fewer of these flame retardants studied at all. Identification of such
evidence gaps is equally valid for focusing primary research. For ex-
ample, the relatively high number of observations of reproductive
toxicity for FR F, but comparatively low number of observations of this
flame retardant in any exposure locations might warrant re-analysis of
samples or new exposure studies to verify whether exposure to this
substance is of concern.
The SEM is also sufficiently flexible that different trends can be
investigated, and different research questions formulated, based on the
priorities of regulators. For example, the number of observations in the
literature which found FR D in aquatic environments might spur further
investigation into the ecotoxicity of this compound. A single SEM ex-
ercise therefore makes efficient use of resources in its potential to meet
the varied needs of several end users.
5. The role of SEMs in wider risk management workflows
In addition to priority setting, SEMs have the potential to fill several
roles within wider workflows.
5.1. Data gathering
Although evidence synthesis methodology can be considered costly
in terms of time and resources, this cost can be dwarfed by the
equivalent resource demands associated with conducting primary re-
search relevant to assessing the hazards associated with exposure to a
chemical, as illustrated with more established examples in the field of
medicine (Glasziou et al., 2006). In an effort to manage these demands,
reduce the production of research waste, and comply with principles
such as the three Rs (European Chemicals Agency, 2018a, 2018b;
National Centre for the Replacement Refinement and Reduction of
Animals in Research, 2018), a key first step in many regulatory work-
flows is the identification and gathering of all pre-existing evidence
relevant to a specific risk management decision. This can be illustrated
in regulatory frameworks such as the European Union's REACH (Re-
gistration, Evaluation, Authorisation and Restriction of Chemicals) in-
itiative, which requires registrants to make an attempt to identify all
available, pre-existing evidence on the hazards associated with the
chemical substance under registration (European Chemicals Agency,
2018a, 2018b). Similarly, REACH imposes a “one substance, one re-
gistration” policy, whereby all parties with an interest in registration of
a substance must share data, minimising repeat testing. Although pro-
moted in guidance documents (European Chemicals Agency, 2016), a
lack of a sufficiently robust methodology for finding, collating, housing
and reporting these data leads to poor transparency, and therefore does
not remove the potential for cherry picking of key studies which may
not be representative of the evidence base as a whole.
SEMs have the potential to provide this much needed transparency.
The nature of a SEM's output being a collection of relevant search re-
sults, and specific information coded from those results, introduces a
greater level of accountability for registrants. Studies are identified by
registrants as “key”, “supporting” etc. based on the perceived relevance,
adequacy and reliability of the evidence they provide for a specific
endpoint, assessed using “sound scientific judgement” (European
Chemicals Agency, 2011). These assignments are aided by application
of the Klimisch criteria (Klimisch et al., 1997) – a rating methodology
criticised for its lack of transparency and failure to consider non-in-
dustry sources of evidence (Ingre-Khans et al., 2019). This poor trans-
parency hinders the appraisal of registrants' choices (e.g. of key study),
and the degree to which those choices can be considered representative
of the wider evidence base. Using SEM methodology alleviates this issue
by requiring registrants to clearly document the efforts of their search
and screening process, constructing a database of the pool of evidence
considered in their evaluations. Additionally, applying code to the
specific extracted study features which influence a decision to assign a
study as “key”, “supporting”, “weight-of-evidence” etc. serves to
document the basis for these decisions in a structured and queryable
way. As registrants submit SEMs at the level of single substances, these
efforts can be merged to build a SEM that spans all registered sub-
stances. This facilitates appraisal of registrants' choices of key study in
the context of the wider evidence base. The ability to explore trends in
the features influencing assignment of key studies may even assist in
refining and improving the registration process – as emerging issues or
shortcomings can be quickly evidenced.
5.2. Problem formulation
Beyond offering improvements in transparency during the data
gathering phase, SEMs may be of particular value to the problem for-
mulation stage of regulatory decision-making. Problem formulation is a
prerequisite to conducting a chemical risk assessment, identifying an
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issue of regulatory relevance around which the assessment will be fo-
cused (Solomon et al., 2016). These issues can be subtle and difficult to
identify at a sufficiently early stage in the field of environmental health,
putting the problem formulation process at risk of focusing on issues of
lower severity or significance. In implementing a SEM with a broad
(lower resolution) coding process, but with a key focus on the hierarchy
of coded data and the nature in which this data is related, trends in the
evidence base can be effectively and efficiently identified. This allows
risk assessors to use these broad, coded parameters to reliably identify
problems in need of further assessment, either through secondary
syntheses (if the SEM presents a sufficiently large evidence cluster) or
primary research (if the SEM indicates an evidence gap).
5.3. Read-across
Identifying trends in the evidence base may also play a significant
role in read-across applications. Read-across allows the toxicologically
relevant properties of a chemical to be inferred by comparison with a
structurally similar chemical of known toxicological behaviour
(European Chemicals Agency, 2017a). Read-across aligns well with the
need to make best use of existing evidence (van Leeuwen et al., 2009),
and the storage of data in a related manner within a SEM could allow
the identification of appropriate read-across scenarios. In filtering an
evidence map by outcome features, exposures which behave in a similar
manner can be identified and investigated further for chemical simi-
larity and/or shared modes of action. This information can be used to
group substances, such that data-rich members of the group can be used
to make predictions about data-poor members, without pursuing fur-
ther primary research (Vink et al., 2010). Conversely, filtering an evi-
dence map by chemical group or structural similarity may allow iden-
tification of shared outcomes, of similar relevance to read-across
applications.
5.4. Evidence surveillance
Once regulation is in place, it is vital that it is kept up to date. Such
is the role of the ongoing, evidence surveillance phase of regulatory
decision-making. Within REACH, registrants are required to update
their registration dossiers “whenever new information is available”
(European Chemicals Agency, 2017b), such that dossiers are living
products. However, a report commissioned by the European Chemicals
Agency (ECHA) found that 64% of REACH registration dossiers sub-
mitted to ECHA since 2008 have never been updated (Amec Foster
Wheeler Environment and Infrastructure UK Limited, 2017). The report
details several obstacles experienced by registrants faced with updating
dossiers, including technical difficulties, issues of ownership or re-
sponsibility for updates among co- and lead registrants, the potentially
labour-intensive nature of updating dossiers and a perception of REACH
registration being the “end of a process”.
Openly accessible and easily updated SEMs may serve to address
such obstacles. As the population of a SEM database does not require
detailed analysis or complex interpretation of the raw data, SEMs could
be amenable to automation. Technological advances in text-mining and
artificial intelligence might assist the automatic screening, extraction
and coding of new information as it is published, based on the data
fields and coding ontologies used to populate the original SEM.
Although some years away from implementation, application of SEM
methodology in the interim will promote fast uptake of such techno-
logical advances.
6. Conclusion
Systematic evidence mapping presents a transparent and robust
methodological framework with which to assess the evidence landscape
at the level of individual chemical risk management and innovation, to
regulatory decision-making in chemicals policy. The broad scope of
SEMs lowers the barrier to evidence synthesis in chemical risk assess-
ment through more efficient use of resources. Future developments in
text mining and machine learning are likely to further reduce the re-
source intensity of the methodology, and of chemical risk assessment in
general. These advances will enable the automatic production of highly
resolved SEMs capable of synthesising evidence or feeding predictive
models.
In the interim pursuit of a more evidence-based approach to che-
micals policy, the resource strain associated with producing a SEM can
be managed through adaptation of the methodology to present day
limitations. Depending on the needs of the user and the constraints of
their use case, SEM methodology is sufficiently flexible that it may be
adapted (e.g. by searching fewer databases, extracting data based on
only title/abstract etc.) without compromising the utility of the end
product in the same way as the results of a synthesis might be adversely
affected by modification of systematic review methodology. By working
closely with stakeholders to define objectives, the scope of the SEM (i.e.
bibliographic databases covered, types of studies included, etc.) can be
adjusted as appropriate to objectives. For example, critical appraisal of
studies may not be imperative to the aim of the SEM and may therefore
be omitted or might be planned as part of a stepwise approach after the
SEM identifies pockets of evidence of interest to stakeholders. Although
designed to reduce the resource strain of SEM exercises, such flexible
adaptation of the methodology does not compromise the fitness-for-
purpose of SEMs as a means of identifying and comparing trends in the
availability of evidence in a vast and heterogeneous information land-
scape.
Consequently, examples of research activities producing fit-for-
purpose SEM outputs and/or developing aspects of SEM methodology
specific to chemicals policy contexts are beginning to emerge (Beverly,
2019), with research institutes such as NTP-OHAT and The Endocrine
Disruption Exchange (TEDX) conducting evidence mapping activities
(NTP-OHAT, 2019; The Endocrine Disruption Exchange, 2019). A key
consideration for these emerging efforts is the accessibility of SEMs'
queryable output for non-technical audiences. To this end, researchers
have made use of a variety of readily available and user-friendly tools
(e.g. Datawrapper GmbH, 2019; IBM, 2019; QlikTech International AB,
2019; Tableau Software, 2019 etc.) to facilitate visualization of, and
promote interaction with, the data collated in evidence surveillance
exercises (e.g. Pelch et al., 2019; Walker et al., 2018). These tools may
similarly serve to lower the barrier to accessing (as well as producing)
SEMs, provided the underlying database is made available for more
specialist users. Although future technological advances will have sig-
nificant implications for the production and use of SEMs, these efforts
indicate how SEM methodology can be effectively applied in present
day, highlighting how SEMs can be adapted for engaging with a variety
of stakeholders. More immediate establishment of (adapted) SEM in-
frastructure in current regulatory workflows will therefore not only
lower resource barriers to evidence-based decision-making, but will
ensure that technological advances in automation, and in SEM metho-
dology itself, can be readily exploited by regulatory decision-makers in
chemicals risk management.
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